Palantir's NHS Platform: Slower, Costlier, Unproven

Palantir's NHS Platform: Slower, Costlier, Unproven

FDP Costs Rise to £480 Million, £1 Billion Possible

Capital commitments for the Federated Data Platform (FDP) have escalated, with initial estimates rising to £360 million, then £480 million, and potential whole-life costs exceeding £1 billion if fully deployed, Foxglove documented. Democracy for Sale highlighted that this escalating expenditure is compounded by a separate £8 million Department of Health and Social Care contract with KPMG to promote FDP adoption. The UK government has forecasted that the overall FDP program will deliver £5 of benefits for every £1 spent, as the London School of Economics reported. This forecast stands against the NHS's admission that it cannot draw a causal link between the FDP and reported outcomes, leaving the financial benefits unproven.

Proprietary "Black Boxes" Limit Accountability

Palantir's algorithms often operate as "black boxes," lacking the transparency necessary for thorough public examination and independent auditing, the London School of Economics and P4SC4L explained. Medact and P4SC4L pointed out that the proprietary nature of the software makes it difficult to audit why specific outputs are produced, thereby complicating the assignment of liability for erroneous decisions. P4SC4L documented that the House of Commons committee has recommended requiring independent audits of workflows and clarifying citizens' rights to appeal algorithmic decisions to ensure accountability. While Slashdot and GoPenAI observed that Palantir's historical algorithmic deployments generally show low error rates in their core data integration functions, Medact and Palantir's SEC filings indicate that the typical allocation of financial risk in its sector deployments structurally passes these burdens downstream to clients through indemnity limitations.

NHS Trusts Absorb Financial Risk

The London School of Economics and P4SC4L reported that specific financial caps on Palantir's liability for data breaches or algorithmic errors under the current NHS contract remain undisclosed. A peer-reviewed publication and Hansard confirm that the Palantir FDP in the NHS has not triggered any specific named formal audits or patient appeals directly due to an algorithmic error causing adverse patient outcomes. While several English NHS trusts confirmed data quality issues with discharge-delay records, a SAGE Publishing journal explained that these were characterized as data quality problems rather than supplier failures or algorithmic errors.

NHS Financially Exposed to £1 Billion FDP Costs

With contract costs already exceeding initial estimates and potentially reaching over £1 billion, the NHS is financially exposed to the platform's inefficiencies over the contract term. The NHS faces significant financial exposure due to the unproven efficiency gains of Palantir's Federated Data Platform and the proprietary nature of its software. This situation, coupled with contractual structures that limit Palantir's liability, shifts the financial burden of potential algorithmic errors, audits, and appeals primarily onto NHS Trusts and Integrated Care Boards.


Download the full research report (PDF)